WSK-IM02 for Advanced Cancer With Fluid Buildup
Part of Cancer, Lungs & breathing clinical trials.
This early-stage trial tests a new drug (WSK-IM02) delivered directly into the space around your lungs or abdomen to treat fluid buildup caused by advanced cancer. The drug is designed to reduce this fluid and improve your symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–75 years old
- You have advanced solid cancer confirmed by biopsy or imaging with fluid buildup (pleural or peritoneal effusion) in your chest or abdomen
- You have already tried standard cancer treatments and developed this fluid buildup as a result
- You are willing and able to have a needle drainage procedure or use an existing drainage tube for the study drug
- Your overall health status allows for this treatment (ECOG score 0–2, or 3 if drainage would improve it)
- You do not have active infections, certain blood disorders, uncontrolled high blood pressure, or autoimmune diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, SIM0388, for people whose cancer has spread and caused fluid buildup in the belly. It aims to see if the drug is safe and can help reduce the fluid.
This trial tests a drug called tocilizumab, which is given through the tube that drains fluid from your chest or belly. The goal is to see if it can help control cancer-related fluid buildup and improve symptoms.
This early-phase trial tests an experimental drug called GK02 for people with advanced cancer who have fluid buildup in the belly (malignant ascites). The drug is given directly into the belly to try to reduce the fluid and control symptoms.
This phase 1 trial tests a new drug called WSK-IM02 for women with ovarian cancer that has stopped responding to platinum-based chemotherapy. It aims to see if the drug is safe and if it can help shrink tumors.
This trial tests a treatment using your own immune cells (T cells) to fight cancer that has spread to the lining of the lung and is causing fluid buildup. It may help if other standard treatments have stopped working.
This trial tests a new drug called MT027 for people with advanced cancer that has spread to the lining around the lungs (pleura) and caused fluid buildup. The drug targets a marker on cancer cells called B7-H3. It may help control the fluid and the cancer.
Hear when a new Malignant Ascites trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.